COMMUNIQUÉS West-GlobeNewswire

PCI Biotech: Second quarter and first half-year 2018 results

30/08/2018 - 07:30

Oslo (Norway), 30 August 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim second quarter and first half-year 2018 result. Please find enclosed the report and [...]

MDxHealth (R): MDxHealth Reports Half Year 2018 Results

30/08/2018 - 07:01

NEWS RELEASE REGULATED INFORMATION INTERIM FINANCIAL REPORT Good Operational Progress and Healthy Double-Digit Growth of Clinical Testing Volumes Conference call for analysts and investors today at 15:00 CET / 09:00 EST [...]

MDxHealth (R) : MDxHealth communique ses résultats financiers pour le premier semestre 2018

30/08/2018 - 07:01

COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES RAPPORT FINANCIER INTERMÉDIAIRE Des progrès d'exploitation satisfaisants et une croissance solide à deux chiffres des volumes de tests cliniques Conférence téléphonique [...]

IBA SA : IBA and Parkway Pantai sign contract to install proton therapy system in Singapore

30/08/2018 - 07:01

IBA and Parkway Pantai sign contract to install proton therapy system in Singapore First Proteus ® ONE contract in South East Asia and 24 Proteus ® ONE now sold globally Louvain-la-Neuve, Belgium, 30 August 2018 - IBA ( [...]

IBA SA : IBA et Parkway Pantai signent un contrat pour l'installation d'un système de protonthérapie à Singapour

30/08/2018 - 07:01

IBA et Parkway Pantai signent un contrat pour l'installation d'un système de protonthérapie à Singapour Premier contrat Proteus ® ONE en Asie du Sud-Est et 24 e Proteus ® ONE vendu dans le monde Louvain-la-Neuve, [...]

Biocartis Group NV: Biocartis announces 2018 half-year results on 6 September 2018

30/08/2018 - 07:01

PRESS RELEASE : REGULATED INFORMATION Thursday 30 August 2018, 07:00 CEST BIOCARTIS ANNOUNCES 2018 HALF-YEAR RESULTS ON 6 SEPTEMBER 2018 Mechelen, Belgium , 30 August 20 18 - Biocartis Group NV (the 'Company' or ' [...]

Bone Therapeutics SA announces H1 results for 2018

30/08/2018 - 07:01

Regulated information The interim financial report is prepared in accordance with article 13 of the Royal Decree on the obligations of issuers of financial instruments admitted to trading on a regulated market and can [...]

Bone Therapeutics SA publie ses résultats du premier semestre 2018

30/08/2018 - 07:01

Information réglementée Le rapport semestriel est préparé conformément au prescrit de l'article 13 de l'Arrêté Royal relatif aux obligations des émetteurs d'instruments financiers admis à la négociation sur un marché [...]

Vistin Pharma ASA : 20 per cent revenue growth in second quarter 2018

30/08/2018 - 07:01

Oslo, Norway, 30 August 2018 Vistin Pharma delivers a revenue growth of 20 percent from NOK 45.3 million in the second quarter 2017 to NOK 54.6 million in the second quarter 2018. The underlying demand for metformin is [...]

Probiodrug Reports Financial Results for H1 2018 and Corporate Update

30/08/2018 - 07:01

Probiodrug Reports Financial Results for H1 2018 and Corporate Update HALLE (SAALE), Germany, 30 August 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel [...]

Kiadis Pharma announces resignation of Robbert van Heekeren and appoints Scott A. Holmes as new Chief Financial Officer

30/08/2018 - 07:01

Kiadis Pharma announces resignation of Robbert van Heekeren and appoints Scott A. Holmes as new Chief Financial Officer Amsterdam, The Netherlands, August 30, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company [...]

ProLynx et Daiichi Sankyo annoncent la mise au point d’une technologie permettant d’étendre la demi-vie des petites molécules dans l’œil

30/08/2018 - 05:39

SAN FRANCISCO, 30 août 2018 (GLOBE NEWSWIRE) -- ProLynx et Daiichi Sankyo Company, Limited ont annoncé aujourd’hui la publication d’un article dans le journal TVST intitulé « A controlled release system for long-acting [...]

MPX Bioceutical Corporation Reports Financial Results for Its Fiscal First Quarter of 2019

30/08/2018 - 00:44

Record Quarterly Revenues increased 224% to $14.5M TORONTO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) today reports financial results for its [...]

Assure Holdings Reports Second Quarter 2018 Financial Results

30/08/2018 - 00:32

– Revenue Increases by 46% to $6.0 Million, Net Income Increases to $3.3 Million – – Management to Discuss Second Quarter Results via Conference Call on Thursday, August 30, 2018, at 11:00 A.M. Eastern Time – DENVER, [...]

ContraFect to Present at Two Upcoming Investor Conferences

29/08/2018 - 23:30

YONKERS, N.Y., Aug. 29, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]

Adverum Biotechnologies Announces IND Active for ADVM-022, a Novel Gene Therapy to Treat Wet Age-related Macular Degeneration

29/08/2018 - 23:30

OPTIC Phase 1 clinical trial initiation expected in 4Q18 Patients to receive a single administration of ADVM-022 delivered intravitreally 6 top U.S. retinal centers participating in the new OPTIC trial MENLO PARK, Calif [...]

MediciNova Announces the Publication of Results of the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS in the New England Journal of Medicine

29/08/2018 - 23:00

LA JOLLA, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]

EDAP TMS SA : EDAP Reports 2018 Second Quarter Results

29/08/2018 - 22:36

Receives FDA clearance for novel Focal One device for prostate tissue ablation LYON, France, August 29, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound, announced today [...]

Amedisys Partners with Medalogix to Drive Home Health Innovation

29/08/2018 - 22:30

Investment in Nashville Based Predictive Analytics Platform NASHVILLE, Tenn., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America's leading independent home health, hospice care and personal care [...]